NCT04065503 is a EARLY_PHASE1 clinical trial of Probiotic Strains in Healthy, sponsored by University of Florida.

Who is sponsoring NCT04065503?

NCT04065503 is sponsored by University of Florida.

What drugs are being tested in NCT04065503?

Interventions in NCT04065503: Probiotic Strains.

Is NCT04065503 still recruiting?

NCT04065503 is currently completed. Last updated 19 January 2021.

Last reviewed 2021-01-19 · How we verify

NCT04065503

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Probiotic Detection and Persistence Study

Completed EARLY_PHASE1 Last updated 19 January 2021

What this trial tests

EARLY_PHASE1 trial testing Probiotic Strains in Healthy in 31 participants. Completed in 31 December 2020.

Timeline

6 December 2019

Primary endpoint
26 February 2020

31 December 2020

Quick facts

Lead sponsor	University of Florida
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	31
Start date	6 December 2019
Primary completion	26 February 2020
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

Probiotic Strains — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Florida

Who can join

Adults 18 to 55, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study are to determine how long it takes for the strains of a probiotic formulation to be detected in feces after the start of an intervention, how long they persist after the end of the intervention, and the associations between detection and persistence with total gut transit time.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Total Transit Time and Probiotic Persistence in Healthy Adults: A Pilot Study.
Tremblay A, Auger J, Alyousif Z, Calero SEC, et al · · 2023 · cited 8× · PMID 37019866 · DOI 10.5056/jnm22031

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04065503 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 19 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04065503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing